However, Chapel et al. [45] reported some mesothelioma cases with a strong and diffuse expression of MOC-31 and/or Ber-EP4 and, therefore, they suggest always combining one of these antibodies with an immunohistochemical panel that includes claudin-4 and two mesothelial lineage biomarkers. This evidence concerns the gene CLDN4 and mesothelioma.